Primary vaccination with the 10-valent pneumococcal non-typeable <it>Haemophilus influenzae </it>protein D conjugate vaccine (PHiD-CV) in infants in Mali and Nigeria: a randomized controlled trial
<p>Abstract</p> <p>Background</p> <p>Pneumonia is still the leading cause of death among children in Africa, and pneumococcal serotypes 1 and 5 are frequently isolated from African children with invasive pneumococcal disease below the age of 5 years. The immunogenicity,...
Saved in:
Main Authors: | Dicko Alassane (Author), Odusanya Olumuyiwa O (Author), Diallo Abdoulbaki I (Author), Santara Gaoussou (Author), Barry Amadou (Author), Dolo Amagana (Author), Diallo Aminata (Author), Kuyinu Yetunde A (Author), Kehinde Omolara A (Author), François Nancy (Author), Borys Dorota (Author), Yarzabal Juan P (Author), Moreira Marta (Author), Schuerman Lode (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2011-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Safety profile of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV)
by: Sven Arne Silfverdal, et al.
Published: (2017) -
Immunization with 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) according to different schedules in infants in South Africa: a phase III trial
by: Shabir A Madhi, et al.
Published: (2017) -
A 6-year safety surveillance of 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in South Korea
by: Soon Min Lee, et al.
Published: (2018) -
Cost-effectiveness analysis of infant pneumococcal vaccination with PHiD-CV in Korea
by: Xu-Hao Zhang, et al.
Published: (2018) -
Estimated public health impact of human rotavirus vaccine (HRV) and pneumococcal polysaccharide protein D-conjugate vaccine (PHiD-CV) on child morbidity and mortality in Gavi-supported countries
by: Alen Marijam, et al.
Published: (2022)